Entscheidungen
| Datum | Fall | Kammer | Verfahrensart | Antrag | Ausgang | Zusammenfassung |
|---|---|---|---|---|---|---|
| 2025-05-13 | ACT_597355/2023 | Dusseldorf LD | Infringement Action | Verletzung (Hauptsache) | Nicht verletzt | The Düsseldorf Local Division dismissed Sanofi and Regeneron's infringement action and Amgen's counterclaim for revocation concerning EP3536712 (a second medical use patent for evolocumab in paediatric patients), finding no infringement of the second medical use claim and that the counterclaim for revocation was also unfounded, with each side bearing the costs of the proceedings they lost. |